Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 2
1982 1
1984 2
1985 1
1986 2
1987 2
1988 1
1992 1
1993 3
1994 1
1995 4
1997 2
1998 3
1999 5
2000 4
2001 3
2002 6
2003 5
2004 5
2005 8
2006 5
2007 5
2008 6
2009 11
2010 7
2011 6
2012 10
2013 9
2014 10
2015 9
2016 9
2017 9
2018 7
2019 4
2020 6
2021 6
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

166 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Isenberg D, Furie R, Jones NS, Guibord P, Galanter J, Lee C, McGregor A, Toth B, Rae J, Hwang O, Desai R, Lokku A, Ramamoorthi N, Hackney JA, Miranda P, de Souza VA, Jaller-Raad JJ, Maura Fernandes A, Garcia Salinas R, Chinn LW, Townsend MJ, Morimoto AM, Tuckwell K. Isenberg D, et al. Among authors: hwang o. Arthritis Rheumatol. 2021 Oct;73(10):1835-1846. doi: 10.1002/art.41811. Epub 2021 Aug 24. Arthritis Rheumatol. 2021. PMID: 34042314 Clinical Trial.
Role of matrix metalloproteinase-3 in neurodegeneration.
Kim EM, Hwang O. Kim EM, et al. Among authors: hwang o. J Neurochem. 2011 Jan;116(1):22-32. doi: 10.1111/j.1471-4159.2010.07082.x. Epub 2010 Dec 2. J Neurochem. 2011. PMID: 21044079 Free article. Review.
166 results